Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 88-3403879 · Snapshot of IRS recognition, filing currency, financial health, and governance.
FY2025 filed as a Form 990-N placeholder. The IRS has not yet released this organization’s full Form 990 for FY2025. All data on this profile reflects the most recent substantive 990 filing; the placeholder year appears in the Financials tab with no breakdown.
Started in 2022 with mission to make meaningful contribution to science and therapeutics development Maragin operates similar to a university lab and collaborates with other university labs aiming to bridge the gap between scientific discovery and validation of therapeutic approaches. Organization has a goal of 20 academic collaborations 30 programs 50 papers and 5 proof-of-concept validations per year. Once developed and validated the therapeutic programs will graduate and move onto big pharma for further development. There is no venture capital or investor in what Maragin does. Therefore Maragin works on programs based on scientific merits and can take economically risky approaches which are often necessary for ground-breaking discovery and development.
Total Revenue
$0
FY2025
Total Expenses
—
FY2025
Net Assets
$0
Program Ratio
—
expenses on programs
Employees
1
Volunteers
2
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.